Navigation Links
Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
Date:1/18/2008

LONDON, January 18 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRND) today announced that, at a General Meeting held yesterday, its shareholders approved a 1 for 10 reverse split of each of its Ordinary Shares. The reverse split became effective as of the close of business yesterday, January 17, 2008.

Thomas Lynch, Amarin Chairman and Chief Executive Officer, commented "We are very pleased to report that over 95% of the votes cast by our shareholders approved the one-for-ten reverse stock split. We have made good progress in recent months expanding our management team and broadening our pipeline and look forward to executing on our strategy which we believe will drive shareholder value in 2008."

Under customary Nasdaq practice, with effect from today, January 18, 2008, and for a period of 20 trading days, a "D" will be appended to Amarin's Nasdaq ticker symbol and during that period Amarin's Nasdaq ticker symbol will appear as "AMRND".

Pipeline Update

Through 2007, the Company embarked upon a program of broadening its development pipeline with the objective of having multiple late stage programs with an appropriate balance of portfolio risk.

This was facilitated by the achievement of a number of important milestones. Firstly, the completion of a comprehensive analysis of the 12-month data from the US Phase III trial of Miraxion (AMR101) in Huntington's disease (HD) showing a statistically significant benefit with Miraxion over longer periods of treatment, and the corresponding feedback from the U.S. Food and Drug Administration (FDA).

Amarin also conducted a thorough analysis and re-configuration of its existing pipeline from which the Company's cardiovascular initiative was launch
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
2. Amarin Signs Agreement to Acquire Ester Neurosciences
3. Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
4. Amarin Announces Initiation of Cardiovascular Development Strategy
5. Amarin to Present at 4th Annual Bio Investor Forum
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. YM BioSciences provides update on AeroLEF(TM) clinical development program
8. ViroPharma Provides 2008 Outlook
9. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
10. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
11. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Toronto, Ontario (PRWEB) May 22, 2013 ... of advanced sound therapy for tinnitus treatment. AudioNotch ... Destination Hearing . With clinic locations in both ... trusted provider of audiology and hearing services. AudioNotch's ... Zabell locations. , Upon entering a Destination Hearing ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Envera ... as Fermentation Manager. Mr. McErlean has an extensive ... of leadership positions throughout his career. , ... are very pleased to have Mike join our team”. ... installed large scale fermentation and downstream processing ...
(Date:5/22/2013)... The ability to sequence genomes has ... encode. There are now a suite of applications ... protected fragments) that dramatically expand our ability to ... Dr. Jonathan Weissman, an Investigator with the University ... Institute, who will present recent applications of their ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2
... Palatin Technologies,Inc. (Amex: PTN ) will announce ... period ended March 31, 2008 before the open of,the ... Company will also conduct a teleconference and live audio ... 2008 at which they,will discuss the results of operations ...
... Bulletin Board: GNTA) today announced financial results,for the quarter ended ... has recorded significant milestones including the following:, -- ... G4544 for bone disease completes single dose-trial in 505(b)(2) ... oral taxane and new clinical-stage product ...
... Nutrition 21, Inc.,(Nasdaq: NXXI ), the developer ... Chromax(R), Advanced Memory Formula(TM) and Diabetes,Essentials(TM) -- brands ... health, enhance memory and reduce chronic joint,pain, today ... fiscal,year 2008 ended March 31, 2008., For ...
Cached Biology Technology:Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 8Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 2Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 3Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 4Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 5Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 6Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 7Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 8
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
(Date:5/22/2013)... Plastic additives known as phthalates (pronounced THAL-ates) are ... up in flooring, plastic cups, beach balls, plastic ... Disease Control and Preventionthe bodies of most Americans. ... increasing scrutiny. A growing collection of evidence suggests ... packaging and mix with food) may cause significant ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
... Johns Hopkins infectious disease specialists who have spent more ... AIDS worldwide are warning that limited international relief supplies ... and the Caribbean will not get to those who ... an article appearing in the American Journal of Public ...
... team of researchers, led by Steven A. Rosenberg, M.D., ... Institutes of Health, have found that patients with advanced ... a significant reduction in the size of their cancers ... immunotherapy consisted of a combination of chemotherapy and reintroduction ...
... team of researchers at the Universitat Autònoma de Barcelona ... sensors have the same size and thickness as a ... chains to several minutes or a few hours, depending ... many different tasks, ranging from paternity tests and identifying ...
Cached Biology News:Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma 2New miniaturised chip dramatically reduces time taken for DNA analysis 2New miniaturised chip dramatically reduces time taken for DNA analysis 3
... RSH-4000 is the only microplate sealer with ... long walkaway times with a variety of ... Fully automated with integrated stacker and 240-plate ... EX for use in small workcells , ...
... provides a comprehensive service for custom ... peptide microarrays synthesized on Paraflo microfluidic ... proteins/antibodies or serum samples. This comprehensive ... designs, binding assays using sample(s) provided ...
... glutathione-S-transferase (GST) is commonly used as a ... coli (1). The GSTTag sequence has been ... some cases the solubility of its fusion ... folded form, GSTTag fusion proteins can be ...
... compatible with BioTeks microplate washers, dispensers ... use and walkaway automation are guaranteed ... used with the ELx405 washer or ... small footprint fits easily in most ...
Biology Products: